Clinical Trial Update: Nintedanib Treatment in Unicentric Castleman Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nintedanib for unicentric Castleman disease. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castleman Disease
• Unicentric Castleman Disease

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Castleman Disease | Phase 2 | Status: NOT_YET_RECRUITING